Literature DB >> 11323042

Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis.

S Alamowitch1, M Eliasziw, A Algra, H Meldrum, H J Barnett.   

Abstract

BACKGROUND: Carotid endarterectomy benefits patients with symptomatic stenosis of 70-99% in the internal carotid artery, with smaller benefit for 50-69% stenosis. The benefit of carotid endarterectomy in patients of 75 years and older remains unclear.
METHODS: Patients aged 75 years or older from the North American Symptomatic Carotid Endarterectomy Trial were compared with those aged 65-74 years and less than 65 years for baseline characteristics and risk of ipsilateral ischaemic stroke at 2 years by degree of stenosis and treatment group.
FINDINGS: Among patients with 70-99% stenosis, the absolute risk reduction of ipsilateral ischaemic stroke with carotid endarterectomy was 28.9% (95% CI 12.9-44.9) for patients aged 75 years or older (n=71), 15.1% (7.2-23.0) for those aged 65-74 years (n=285), and 9.7% (1.5-17.9) for the youngest group (n=303). Among patients with 50-69% stenosis, the absolute risk reduction was significant only in those of 75 years and older (n=145; 17.3% [6.6-28.0]). The perioperative risk of stroke and death at any degree of stenosis was 5.2% for the oldest group, 5.5% for 65-74 years, and 7.9% for less than 65 years. The number of patients aged 75 years or older needed to treat to prevent one ipsilateral stroke within 2 years was three with 70-99% stenosis and six with 50-69% stenosis.
INTERPRETATION: In the prevention of ipsilateral ischaemic stroke, elderly patients with 50-99% symptomatic carotid stenosis benefited more from carotid endarterectomy than younger patients did. To achieve this treatment benefit, surgeons must be skilled and patients with other life-threatening illnesses must be excluded.

Entities:  

Mesh:

Year:  2001        PMID: 11323042     DOI: 10.1016/S0140-6736(00)04332-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Recent developments in neurology.

Authors:  Samuel Wiebe; Michael W Nicolle
Journal:  BMJ       Date:  2002-03-16

Review 2.  Symptomatic carotid artery stenosis.

Authors:  L J Kappelle
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

3.  [Controversies in the treatment of carotid stenoses. Present state of research and evidence-based medicine].

Authors:  H-H Eckstein; P Heider; O Wolf; M Barone; M Hanke
Journal:  Chirurg       Date:  2004-07       Impact factor: 0.955

Review 4.  [Treatment of arteriosclerotic carotid stenosis: an overview].

Authors:  T Struffert; I Grunwald; C Roth; W Reith
Journal:  Radiologe       Date:  2004-10       Impact factor: 0.635

Review 5.  [Vascular surgery in the elderly].

Authors:  D Böckler; H Schumacher; J-R Allenberg
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

Review 6.  [Cerebrovascular diseases].

Authors:  P J Kuhlencordt; J Röling; U Hoffmann
Journal:  Internist (Berl)       Date:  2009-08       Impact factor: 0.743

7.  Primary Angioplasty Versus Stenting for Endovascular Management of Intracranial Atherosclerotic Disease Following Acute Ischemic Stroke.

Authors:  Mark R Villwock; David J Padalino; Raghu Ramaswamy; Eric M Deshaies
Journal:  J Vasc Interv Neurol       Date:  2016-06

8.  Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience.

Authors:  Carole L White; Jeff M Szychowski; Pablo E Pergola; Thalia S Field; Robert Talbert; Helena Lau; Kalyani Peri; Oscar R Benavente
Journal:  J Am Geriatr Soc       Date:  2015-04-06       Impact factor: 5.562

Review 9.  The appropriate use of carotid endarterectomy.

Authors:  Henry J M Barnett; Heather E Meldrum; Michael Eliasziw
Journal:  CMAJ       Date:  2002-04-30       Impact factor: 8.262

10.  Small vessel versus large vessel vascular dementia: risk factors and MRI findings.

Authors:  S S Staekenborg; E C W van Straaten; W M van der Flier; R Lane; F Barkhof; P Scheltens
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.